HCA

HCA Healthcare, Inc. - Q1 2008 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2008. HCA Inc. is a holding company whose affiliates own and operate 161 hospitals and 101 freestanding surgery centers across 20 U.S. states and England. The company operates under a recapitalized structure following a 2006 merger with Hercules Acquisition Corporation, resulting in significant leverage. As of April 30, 2008, there were 94,180,400 shares of voting common stock outstanding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 6.7% year-over-year, driven by a 6.7% increase in revenue per equivalent admission. However, equivalent admissions remained flat, and consolidated admissions decreased 0.5%.
• Profitability Decline: Net income decreased 5.8% to $170 million. Income before taxes fell 6.5% to $288 million.
• Bad Debt Increase: The provision for doubtful accounts rose significantly to 12.5% of revenues (from 10.3% in Q1 2007), attributed to a 5.3% increase in same-facility uninsured admissions and a 9.3% increase in uninsured emergency room visits.
• Cost Pressures: Salaries and benefits increased 7.2% per equivalent admission due to labor rate increases averaging 4.7%. Supply costs per equivalent admission rose 6.3%.
• Debt Management: Interest expense decreased $27 million due to a lower average debt balance and a reduction in the average interest rate from 7.7% to 7.2%. The company repurchased $500 million of outstanding debt during the quarter.
• Facility Sales: Gains on sales of facilities increased to $51 million from $5 million in the prior year.

Outlook, Risks, and Contingencies

• Liquidity: Management expects cash flows from operations and available credit facilities ($1.897 billion available) to meet liquidity needs for the next 12 months. Capital expenditures are expected to approximate $1.65 billion in 2008.
• Tax Disputes: The company is contesting IRS examinations for tax years 2001 through 2006. The liability for unrecognized tax benefits was $882 million as of March 31, 2008. Management believes recorded provisions are adequate but acknowledges the possibility of material adverse effects if disputes are resolved unfavorably.
• Market Risk (ARS): The company's insurance subsidiary holds $661 million in auction rate securities (ARS). Due to market illiquidity and failed auctions, these securities are classified as Level 3 fair value measurements. While currently valued at par, there is a risk of other-than-temporary impairment if market conditions worsen.
• Regulatory Risk: The company is subject to a Corporate Integrity Agreement (CIA) with the Department of Health and Human Services. Violations could result in fines or exclusion from Medicare/Medicaid programs. Additionally, Texas Medicaid supplemental payments are subject to federal review and deferral.
• Legal Proceedings: Various lawsuits are pending, including an ERISA class action (agreement in principle to settle) and a class action alleging nurse understaffing (dismissed but appealed).

Investor Verification Checklist

• Uninsured Patient Mix: Verify the sustainability of the 12.5% bad debt provision given the rising trend in uninsured admissions and ER visits.
• Auction Rate Securities (ARS): Monitor the liquidity status of the $661 million ARS portfolio and potential impairment charges if the market does not recover.
• Tax Liability Resolution: Track the status of IRS audits for years 2001-2006 and the potential impact on the $882 million unrecognized tax benefit liability.
• Debt Service Capacity: Assess the ability to service $27.5 billion in debt given the decline in Adjusted Segment EBITDA to $1.18 billion.
• Texas Medicaid Funding: Confirm the status of federal reviews regarding Texas Medicaid supplemental payments and their impact on future revenue recognition.